UNCY
Unicycive Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.16
−2.64%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.82x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 1.26x
Liquidity & coverage
- Current ratio
- 3.81x
- Quick ratio
- 3.81x
- Cash ratio
- 3.28x
- Interest coverage
- -789.12x
- EBITDA / interest
- -821.93x
- Working capital
- $52.6M
Cash & dividend
- FCF / debt
- -41.50x
- Cash flow / debt
- -41.49x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026